No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer
Annals of Nuclear Medicine · 2024
DOI: 10.1007/s12149-024-01927-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Nuclear Medicine, 2024. Verfasst von Xia Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, No. 519 Kunzhou R…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Staging, Bone Neoplasms. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan digitalization, development and application of biotic resource, The Outstanding Youth Science Foundation of Yunnan Basic Research Project.
Abstract (Originalsprache)
OBJECTIVE: To investigate the survival benefit of preoperative bone scan in asymptomatic patients with early-stage non-small cell lung cancer (NSCLC). METHODS: This retrospective study included patients with radical resection for stage T1N0M0 NSCLC between March 2013 and December 2018. During postoperative follow-up, we monitored patient survival and the development of bone metastasis. We compared overall survival, bone metastasis-free survival, and recurrence-free survival in patients with or without preoperative bone scan. Propensity score matching and inverse probability of treatment weighting were used to minimize election bias. RESULTS: A total of 868 patients (58.19 ± 9.69 years; 415 men) were included in the study. Of 87.7% (761 of 868) underwent preoperative bone scan. In the multivariable analyses, bone scan did not improve overall survival (hazard ratio [HR] 1.49; 95% confidence intervals [CI] 0.91-2.42; p = 0.113), bone metastasis-free survival (HR 1.18; 95% CI 0.73-1.90; p = 0.551), and recurrence-free survival (HR 0.89; 95% CI 0.58-1.39; p = 0.618). Similar results were obtained after propensity score matching (overall survival [HR 1.28; 95% CI 0.74-2.23; p = 0.379], bone metastasis-free survival [HR 1.00; 95% CI 0.58-1.72; p = 0.997], and recurrence-free survival [HR 0.76; 95% CI 0.46-1.24; p = 0.270]) and inverse probability of treatment weighting. CONCLUSION: There were no significant differences in overall survival, bone metastasis-free survival, and recurrence-free survival between asymptomatic patients with clinical stage IA NSCLC with or without preoperative bone scan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, No. 519 Kunzhou Road, Xishan District, Kunming, 650118, Yunnan, China.
- Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
- Department of Nuclear Medicine, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, 650118, China.
- Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, No. 519 Kunzhou Road, Xishan District, Kunming, 650118, Yunnan, China. lizhenhui@kmmu.e…
Förderung
- National Natural Science Foundation of China
- Yunnan digitalization, development and application of biotic resource
- The Outstanding Youth Science Foundation of Yunnan Basic Research Project
- The Yunnan Basic Research Project
Zitieren
APA
Zheng, X., Li, C., Ai, J., Dong, G., Long, M., Li, M., Qiu, S., Huang, Y., Yang, G., Zhang, T., & Li, Z. (2024). No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-024-01927-3
Vancouver
Zheng X, Li C, Ai J, Dong G, Long M, Li M, et al. No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer. Annals of Nuclear Medicine. 2024. doi:10.1007/s12149-024-01927-3
BibTeX
@article{Zheng2024,
author = {Zheng, Xia and Li, Chunxia and Ai, Jing and Dong, Guili and Long, Man and Li, Mingyi and Qiu, Shilin and Huang, Yanni and Yang, Guangjun and Zhang, Tao and Li, Zhenhui},
title = {No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer},
journal = {Annals of Nuclear Medicine},
year = {2024},
doi = {10.1007/s12149-024-01927-3}
}
EUVIMED